These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1298072)

  • 1. Towards a malaria vaccine: riding the rollercoaster between unrealistic optimism and lethal pessimism.
    Saul A
    Southeast Asian J Trop Med Public Health; 1992 Dec; 23(4):656-71. PubMed ID: 1298072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asexual blood-stage malaria vaccine development: facing the challenges.
    Genton B; Reed ZH
    Curr Opin Infect Dis; 2007 Oct; 20(5):467-75. PubMed ID: 17762779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards the development of the ideal malaria vaccine. A decade of progress in a difficult field.
    Good MF
    Med J Aust; 1991 Feb; 154(4):284-9. PubMed ID: 1994206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malaria vaccination: status of development and prospects].
    Kollaritsch H; Stemberger H
    Wien Med Wochenschr; 1991; 141(12):284-7. PubMed ID: 1949823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards the development of malaria vaccines.
    Malkin E; Dubovsky F; Moree M
    Trends Parasitol; 2006 Jul; 22(7):292-5. PubMed ID: 16707275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
    Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waiting for the vaccine: sporozoite vaccine research entails important progress in malaria epidemiology.
    Esposito F; Gambella R; Modiano D; Lamizana L; Lombardi S; Rotigliano G; Habluetzel A
    Parassitologia; 1991 Apr; 33(1):85-91. PubMed ID: 1841198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
    Good MF
    Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens.
    Mahajan RC; Farooq U; Dubey ML; Malla N
    Indian J Pathol Microbiol; 2005 Oct; 48(4):429-38. PubMed ID: 16366089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Achievements and problems in the development of malaria vaccines].
    Martínez-Gómez F
    Rev Latinoam Microbiol; 1993; 35(3):319-25. PubMed ID: 8047736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.